Nasdaq:US$15.41 (+0.36) | HKEX:HK$24.70 (+1.15) | AIM:£2.23 (-0.04)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate

1 items
a060704